Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03179566 · ClinicalTrials.gov registry record · NA
Pain and Medication Use Following Surgery
A NA study, sponsored by University of Michigan.
- Completed
- Registry status
- NA
- Development phase
- 391
- Enrollment target
NCT03179566: Completed NA study, sponsored by University of Michigan.
NCT03179566 is a NA study that has completed, run by University of Michigan. The registered enrollment target is 391 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (72% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03179566, a NA study, has completed, sponsored by University of Michigan.
- COMPLETED
- Registry status
- NA
- Development phase
- 391 participants
- Enrollment target
Study Summary
Patients will be randomized to one of two interventions intended to facilitate safe disposal of opioids after cessation following surgery. For pragmatic reasons, participants will be randomized by day to either the information sheet or the disposal bag using a block randomization schedule. To ensuring adequate sample size, patients will be enrolled for a \~4-week period following the 2-week usual care run in period. In the event that the sample size estimate has not been reached after the 4-week intervention period, additional patients will be enrolled accordingly.
Primary Outcome
Patient-reported disposal of left-over opioid medications in any manner
Interventions
- BEHAVIORAL Information Sheet
- BEHAVIORAL Deterra Drug Deactivation System
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 391 participants |
| Start Date | 2017-06-06 |
| Est. Completion | 2017-09-01 |
| Phase | NA |
What the finished NCT03179566 record still lists
NCT03179566 is an interventional study that assigns participants to a tested intervention. The registered 391 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (72% lower).
The record links to 0 conditions, and to 2 interventions - of which Information Sheet is the first listed.
NCT03179566 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03179566 about?
NCT03179566 is a clinical study titled "Pain and Medication Use Following Surgery". Patients will be randomized to one of two interventions intended to facilitate safe disposal of opioids after cessation following surgery. For pragmatic reasons, participants will be randomized by day to either the information sheet or the disposal bag using a block randomization schedule. To ensuri...
What is the current status of trial NCT03179566?
This trial is currently completed. It is a NA study. The enrollment target is 391 participants. The study started on 2017-06-06. Estimated completion is 2017-09-01.
What interventions are being tested in trial NCT03179566?
The interventions under investigation include: Information Sheet (BEHAVIORAL), Deterra Drug Deactivation System (BEHAVIORAL).
Who is sponsoring clinical trial NCT03179566?
This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03179566's enrollment target sits among peer trials
391 269th of 2000 higher than 1,732 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06397703 · 392 participants · Phase 2
ADT and SBRT vs SBRT Alone for Unfavorable Intermediate Risk Prostate Cancer
- NCT06625775 · 392 participants · Phase 1
Open-Label Study of BBO-10203 in Subjects With Advanced Solid Tumors
- NCT07220967 · 392 participants · Phase 4
A Study of Antibiotic Delivery to Prevent Infection After Breast Tissue Expander Placement
- NCT07290036 · 392 participants · Phase 1
A Study to Learn if Bimekizumab Given in Different Ways is Safe and Moves Similarly Throughout the Body Over Time in Adults
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI